{
  "query": "incidence gvhd engraftment grade",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT06674382",
          "briefTitle": "Haplo-HSCT for Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myelofibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06078696",
          "briefTitle": "Siplizumab for Sickle Cell Disease Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Anemia, Sickle Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03365661",
          "briefTitle": "QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["High-Risk Acute Myeloid Leukemia", "Treatment-Related Acute Myeloid Leukemia", "Secondary Acute Myeloid Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04942730",
          "briefTitle": "Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Acute Lymphoblastic", "Myeloid Leukemia, Acute", "Biphenotypic Acute Leukemia", "Lymphoblastic Lymphoma", "Myelodysplastic Syndromes", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01232504",
          "briefTitle": "Antifugal Effect of Recombinant Human Granulocyte-macrophage Stimulating Factor (rhGM-CSF) in Patients Post Allo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2013-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Mycoses"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06252870",
          "briefTitle": "Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft Versus Host Disease", "Hematologic Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05289167",
          "briefTitle": "Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-versus-host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03263767",
          "briefTitle": "Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06462365",
          "briefTitle": "Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Malignancy", "GvHD", "GVHD,Acute", "GVHD, Chronic", "Hematopoietic Stem Cell Transplant", "Acute Lymphoblastic Leukemia, Adult B-Cell", "Acute Lymphoblastic Leukemia, Adult T-Cell", "Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia, in Remission", "Cancer Remission"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00054353",
          "briefTitle": "Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-10"
          },
          "completionDateStruct": {
            "date": "2012-10-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Refractory Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06880419",
          "briefTitle": "Anti-CD25 rhMAb for aGVHD Prevention in High-Risk Adults Using the daGOAT Model"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Graft-versus-Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06815003",
          "briefTitle": "Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Graft Versus Host Disease", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04237623",
          "briefTitle": "GM-CSF With Post-Transplant Cyclophosphamide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Transplant-Related Hematologic Malignancy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05917405",
          "briefTitle": "Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-14",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia in Remission"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 302,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01246206",
          "briefTitle": "Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2013-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00369226",
          "briefTitle": "Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-08"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00185679",
          "briefTitle": "Haploid Allogeneic Transplant Using the CliniMACS System"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-11"
          },
          "completionDateStruct": {
            "date": "2010-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors", "Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase", "Myelodysplastic Syndrome (MDS) - High and Intermediate Risk", "Non-Hodgkin's Lymphoma (NHL)", "Chronic Lymphocytic Leukemia (CLL) - Refractory"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04131738",
          "briefTitle": "Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft-versus-host-disease", "Graft Vs Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05757310",
          "briefTitle": "A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Severe Aplastic Anemia", "Refractory Severe Aplastic Anemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01158118",
          "briefTitle": "Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Myelodysplastic Syndromes", "Lymphoma, Non-Hodgkin", "Hodgkin Disease", "Leukemia, Lymphocytic, Chronic, B-Cell", "Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01050790",
          "briefTitle": "Lenalidomide + Azacitidine for Adaptive Immunotherapy -> Auto SCT in Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-01"
          },
          "completionDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06704152",
          "briefTitle": "BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML, Adult Recurrent", "ALL, Recurrent, Adult", "MDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04746209",
          "briefTitle": "Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["B-cell Acute Lymphoblastic Leukemia", "B-cell Childhood Acute Lymphoblastic Leukemia", "B-Cell ALL, Childhood"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01751997",
          "briefTitle": "Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "17 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00324324",
          "briefTitle": "Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "Chronic Myeloproliferative Disorders", "Gestational Trophoblastic Tumor", "Infection", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Neuroblastoma", "Ovarian Cancer", "Testicular Germ Cell Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06986382",
          "briefTitle": "Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2040-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05895201",
          "briefTitle": "High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bone Marrow Transplant Complications", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia, Adult", "Myelodysplastic Syndromes", "Chronic Myelomonocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01620229",
          "briefTitle": "Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Hematopoietic/Lymphoid Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06799195",
          "briefTitle": "Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematological Malignancies", "Graft-versus-Host Disease (GVHD)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00275678",
          "briefTitle": "Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-11"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Blood Stem Cell Transplant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "66 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05800210",
          "briefTitle": "Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Juvenile Myelomonocytic Leukemia", "Myelodysplastic Syndromes", "Chronic Myeloid Leukemia", "Lymphoma, Non-Hodgkin", "Lymphoma, Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05288595",
          "briefTitle": "TCR Alpha/Beta and CD19-deplete Haplo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pediatric Patients", "Hematologic Malignancy", "Other Hematologic Condition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "31 Days",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03438344",
          "briefTitle": "Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Bone Marrow Transplantation Recipient", "Chronic Lymphocytic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Hematopoietic Cell Transplantation Recipient", "Hodgkin Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02997202",
          "briefTitle": "A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 356,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05634915",
          "briefTitle": "Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic Stem Cell Transplantation", "Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07157514",
          "briefTitle": "Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2034-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Myeloid Leukemia", "Acute Myelogenous Leukemia", "Acute Myeloid Leukemia", "Acute Myeloid Leukemia, in Relapse", "Myelogenous Leukemia", "Myelogenous Leukemia, Acute", "Myelogenous Leukemia in Relapse", "Transplant-Related Disorder", "Allogeneic Disease", "Refractory AML"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 306,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05303727",
          "briefTitle": "Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neuroblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 64,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06047886",
          "briefTitle": "UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML", "ALL", "Lymphoid Malignancies", "Myelodysplastic Syndromes", "CML", "Primary Myelofibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Weeks",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04201210",
          "briefTitle": "A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HbS Disease", "Hemoglobin S Disease", "Sickle Cell Anemia", "Sickle Cell Disorders", "Sickling Disorder Due to Hemoglobin S", "Sickle Cell Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 212,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06735690",
          "briefTitle": "Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoblastic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03605927",
          "briefTitle": "CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft-versus-host-disease", "GVHD", "GVHD, Acute"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02996773",
          "briefTitle": "Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myelogenous Leukemia", "Myelodysplastic Syndromes", "Chronic Myelogenous Leukemia", "Lymphoma,Non-Hodgkin", "Lymphoma, Hodgkin", "Lymphoma, Follicular", "Marginal Zone Lymphoma", "Large Cell Lymphoma", "Mantle-Cell Lymphoma", "Gray Zone Lymphoma", "Burkitt Lymphoma", "High Risk Undifferentiated Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02199041",
          "briefTitle": "Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-05-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05290545",
          "briefTitle": "Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematological Malignancies", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 314,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04067180",
          "briefTitle": "Randomized Clinical Study Assessing Haplo vs. URD in AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01621477",
          "briefTitle": "T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myelocytic Leukemia", "Chronic Myelocytic Leukemia", "Juvenile Myelomonocytic Leukemia", "Myelodysplastic Syndrome", "Hodgkin or Non-Hodgkin Lymphoma", "Sarcoma, Myeloid"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00040846",
          "briefTitle": "Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Childhood Burkitt Lymphoma", "Childhood Chronic Myelogenous Leukemia", "Childhood Diffuse Large Cell Lymphoma", "Childhood Immunoblastic Large Cell Lymphoma", "Childhood Nasal Type Extranodal NK/T-cell Lymphoma", "Chronic Phase Chronic Myelogenous Leukemia", "Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma", "Contiguous Stage II Grade 1 Follicular Lymphoma", "Contiguous Stage II Grade 2 Follicular Lymphoma", "Contiguous Stage II Marginal Zone Lymphoma", "Contiguous Stage II Small Lymphocytic Lymphoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Hepatosplenic T-cell Lymphoma", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Nodal Marginal Zone B-cell Lymphoma", "Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma", "Noncontiguous Stage II Grade 1 Follicular Lymphoma", "Noncontiguous Stage II Grade 2 Follicular Lymphoma", "Noncontiguous Stage II Marginal Zone Lymphoma", "Noncontiguous Stage II Small Lymphocytic Lymphoma", "Peripheral T-cell Lymphoma", "Previously Treated Myelodysplastic Syndromes", "Progressive Hairy Cell Leukemia, Initial Treatment", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Adult T-cell Leukemia/Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Anaplastic Large Cell Lymphoma", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent Small Lymphocytic Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Splenic Marginal Zone Lymphoma", "Stage I Adult Diffuse Small Cleaved Cell Lymphoma", "Stage I Childhood Anaplastic Large Cell Lymphoma", "Stage I Childhood Large Cell Lymphoma", "Stage I Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage I Grade 1 Follicular Lymphoma", "Stage I Grade 2 Follicular Lymphoma", "Stage I Mantle Cell Lymphoma", "Stage I Marginal Zone Lymphoma", "Stage I Mycosis Fungoides/Sezary Syndrome", "Stage I Small Lymphocytic Lymphoma", "Stage II Childhood Anaplastic Large Cell Lymphoma", "Stage II Childhood Large Cell Lymphoma", "Stage II Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage II Mycosis Fungoides/Sezary Syndrome", "Stage III Adult Diffuse Large Cell Lymphoma", "Stage III Adult Diffuse Small Cleaved Cell Lymphoma", "Stage III Childhood Anaplastic Large Cell Lymphoma", "Stage III Childhood Large Cell Lymphoma", "Stage III Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage III Grade 1 Follicular Lymphoma", "Stage III Grade 2 Follicular Lymphoma", "Stage III Mantle Cell Lymphoma", "Stage III Marginal Zone Lymphoma", "Stage III Mycosis Fungoides/Sezary Syndrome", "Stage III Small Lymphocytic Lymphoma", "Stage IV Adult Diffuse Large Cell Lymphoma", "Stage IV Adult Diffuse Small Cleaved Cell Lymphoma", "Stage IV Childhood Anaplastic Large Cell Lymphoma", "Stage IV Childhood Large Cell Lymphoma", "Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IV Grade 1 Follicular Lymphoma", "Stage IV Grade 2 Follicular Lymphoma", "Stage IV Mantle Cell Lymphoma", "Stage IV Marginal Zone Lymphoma", "Stage IV Mycosis Fungoides/Sezary Syndrome", "Stage IV Small Lymphocytic Lymphoma", "T-cell Large Granular Lymphocyte Leukemia", "Waldenstrm Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00201240",
          "briefTitle": "Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myelocytic, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01188798",
          "briefTitle": "Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09"
          },
          "completionDateStruct": {
            "date": "2012-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myelocytic Leukemia", "Chronic Myelocytic Leukemia", "Hodgkin's Disease", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Months",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01071226",
          "briefTitle": "Peripheral Blood Stem Cell Transplantation Using the CliniMACS Device"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2020-04-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Diseases (ie, Leukemia, MDS, Lymphoma)", "Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00003335",
          "briefTitle": "Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-01"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft Versus Host Disease", "Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "54 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07162038",
          "briefTitle": "Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Malignancies", "Hematologic Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 155,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05762211",
          "briefTitle": "Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Transplant Complication"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 387,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04859946",
          "briefTitle": "Itacitinib for the Prevention of Graft Versus Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic and Lymphocytic Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07162688",
          "briefTitle": "Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-Versus-Host Disease(GVHD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02345850",
          "briefTitle": "Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Myelodysplasia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 346,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04112810",
          "briefTitle": "Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05166967",
          "briefTitle": "Targeted Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Haploidentical Hematopoietic Stem Cell Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06238245",
          "briefTitle": "Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-28",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft-versus-host Disease", "Hematological Malignancies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02737306",
          "briefTitle": "A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft Vs Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01962415",
          "briefTitle": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Immunodeficiency (PID)", "Congenital Bone Marrow Failure Syndromes", "Inherited Metabolic Disorders (IMD)", "Hereditary Anemias", "Inflammatory Conditions", "Systemic Juvenile Idiopathic Arthritis (sJIA)", "Juvenile Rheumatoid Arthritis (JRA)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Months",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00988715",
          "briefTitle": "Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-04-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Chronic Myelomonocytic Leukemia", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Previously Treated Myelodysplastic Syndrome", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Refractory Anemia With Excess Blasts", "Refractory Cytopenia With Multilineage Dysplasia", "Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts", "Secondary Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03279094",
          "briefTitle": "Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02-24",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02579967",
          "briefTitle": "Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2036-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary T-cell Immunodeficiency Disorders", "Common Variable Immunodeficiency", "Immune System Diseases", "Autoimmune Lymphoproliferative", "Lymphoproliferative Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 354,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "4 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02942173",
          "briefTitle": "CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "GvHD", "Opportunistic Infections", "Graft-versus-Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00963872",
          "briefTitle": "Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03"
          },
          "completionDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Multiple Myeloma", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06125483",
          "briefTitle": "TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic Malignancy", "Relapse/Recurrence", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01788501",
          "briefTitle": "Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft vs Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04669210",
          "briefTitle": "PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft-versus-host-disease", "Stem Cell Transplant Complications", "Acute Myeloid Leukemia", "Acute Lymphoid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 128,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00005799",
          "briefTitle": "Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1999-11"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia", "Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "B-cell Chronic Lymphocytic Leukemia", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Childhood Renal Cell Carcinoma", "Chronic Phase Chronic Myelogenous Leukemia", "Clear Cell Renal Cell Carcinoma", "de Novo Myelodysplastic Syndromes", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Nodal Marginal Zone B-cell Lymphoma", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent Small Lymphocytic Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Splenic Marginal Zone Lymphoma", "Stage III Renal Cell Cancer", "Stage IV Renal Cell Cancer", "T-cell Large Granular Lymphocyte Leukemia", "Type 1 Papillary Renal Cell Carcinoma", "Type 2 Papillary Renal Cell Carcinoma", "Waldenstrm Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04000698",
          "briefTitle": "Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Refractory Acute Myeloid Leukemia", "Refractory Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02333162",
          "briefTitle": "Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Previously Treated Myelodysplastic Syndrome", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Hematologic Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06680661",
          "briefTitle": "ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Lymphatic Leukemia", "Chronic Myelogenous Leukemia", "Myelodysplastic Syndromes", "Myelodysplastic Syndrome Other", "Chronic Myelomonocytic Leukemia", "Lymphoma", "Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04776850",
          "briefTitle": "Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Beta Thalassemia Major", "Sickle Beta 0 Thalassemia", "Sickle Beta Plus Thalassemia", "Sickle Beta Thalassemia", "Sickle Cell Disease", "Sickle Cell-SS Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01339910",
          "briefTitle": "Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia, Myelocytic, Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 272,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01247701",
          "briefTitle": "Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2019-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myeloid Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01882387",
          "briefTitle": "Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03467386",
          "briefTitle": "Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05629260",
          "briefTitle": "The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01186913",
          "briefTitle": "Natural History Study of SCID Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Combined Immunodeficiency (SCID)", "Leaky SCID", "Omenn Syndrome", "Reticular Dysgenesis", "ADA SCID", "XSCID"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 690,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00796562",
          "briefTitle": "Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["MDS", "Leukemias", "Lymphomas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05088356",
          "briefTitle": "Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Allogeneic Hematopoietic Cell Transplantation (HCT)", "Advanced Hematologic Malignancies", "Acute Leukemia", "Chronic Myelogenous Leukemia", "Myelodysplastic Syndromes", "Myeloproliferative Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03922724",
          "briefTitle": "Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Peripheral T-cell Lymphomas", "Lymphoproliferative Disorders", "Immune System Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 330,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04849910",
          "briefTitle": "Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 67,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00950846",
          "briefTitle": "Umbilical Cord Blood Transplant for Congenital Pediatric Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Congenital Pediatric Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00360685",
          "briefTitle": "Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-09"
          },
          "completionDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mucositis", "Graft-versus-host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 89,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04784052",
          "briefTitle": "Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Fanconi Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00153985",
          "briefTitle": "Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-03"
          },
          "completionDateStruct": {
            "date": "2009-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hemoglobinopathies", "Sickle Cell Disease", "Thalassemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00049504",
          "briefTitle": "Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia", "Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Burkitt Lymphoma", "Childhood Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Childhood Nasal Type Extranodal NK/T-cell Lymphoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "de Novo Myelodysplastic Syndromes", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Hematopoietic/Lymphoid Cancer", "Hepatosplenic T-cell Lymphoma", "Intraocular Lymphoma", "Nodal Marginal Zone B-cell Lymphoma", "Peripheral T-cell Lymphoma", "Post-transplant Lymphoproliferative Disorder", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Adult T-cell Leukemia/Lymphoma", "Recurrent Childhood Anaplastic Large Cell Lymphoma", "Recurrent Childhood Grade III Lymphomatoid Granulomatosis", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent Small Lymphocytic Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Multiple Myeloma", "Relapsing Chronic Myelogenous Leukemia", "Secondary Myelodysplastic Syndromes", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Stage II Multiple Myeloma", "Stage III Adult Burkitt Lymphoma", "Stage III Adult Diffuse Large Cell Lymphoma", "Stage III Adult Diffuse Mixed Cell Lymphoma", "Stage III Adult Diffuse Small Cleaved Cell Lymphoma", "Stage III Adult Hodgkin Lymphoma", "Stage III Adult Immunoblastic Large Cell Lymphoma", "Stage III Adult Lymphoblastic Lymphoma", "Stage III Adult T-cell Leukemia/Lymphoma", "Stage III Childhood Hodgkin Lymphoma", "Stage III Chronic Lymphocytic Leukemia", "Stage III Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage III Grade 1 Follicular Lymphoma", "Stage III Grade 2 Follicular Lymphoma", "Stage III Grade 3 Follicular Lymphoma", "Stage III Mantle Cell Lymphoma", "Stage III Marginal Zone Lymphoma", "Stage III Multiple Myeloma", "Stage III Mycosis Fungoides/Sezary Syndrome", "Stage III Small Lymphocytic Lymphoma", "Stage IV Adult Burkitt Lymphoma", "Stage IV Adult Diffuse Large Cell Lymphoma", "Stage IV Adult Diffuse Mixed Cell Lymphoma", "Stage IV Adult Diffuse Small Cleaved Cell Lymphoma", "Stage IV Adult Hodgkin Lymphoma", "Stage IV Adult Immunoblastic Large Cell Lymphoma", "Stage IV Adult Lymphoblastic Lymphoma", "Stage IV Adult T-cell Leukemia/Lymphoma", "Stage IV Childhood Hodgkin Lymphoma", "Stage IV Chronic Lymphocytic Leukemia", "Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma", "Stage IV Grade 1 Follicular Lymphoma", "Stage IV Grade 2 Follicular Lymphoma", "Stage IV Grade 3 Follicular Lymphoma", "Stage IV Mantle Cell Lymphoma", "Stage IV Marginal Zone Lymphoma", "Stage IV Mycosis Fungoides/Sezary Syndrome", "Stage IV Small Lymphocytic Lymphoma", "Testicular Lymphoma", "Waldenstrm Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03983850",
          "briefTitle": "Optimizing PTCy Dose and Timing"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft Versus Host Disease", "Hematologic Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 105,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00977691",
          "briefTitle": "Haploidentical PBMC Transplant for Severe Congenital Anemias"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03298399",
          "briefTitle": "Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02600208",
          "briefTitle": "Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "maximumAge": "23 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00719849",
          "briefTitle": "Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-11"
          },
          "completionDateStruct": {
            "date": "2009-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00923364",
          "briefTitle": "Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["MDS", "Immunodeficiency", "GATA2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00469729",
          "briefTitle": "Efficacy and Safety Study of StemEx, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Malignancies", "Acute Myeloid Leukemia", "Lymphoid Leukemia", "Chronic Myeloid Leukemia", "Hodgkin's Disease", "Non-Hodgkin's Lymphoma", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 101,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03441958",
          "briefTitle": "ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05149365",
          "briefTitle": "Sitagliptin for Prevention of aGVHD After Alternative Donor Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute-graft-versus-host Disease", "Allogeneic Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 190,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02061800",
          "briefTitle": "CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloid Leukemia (CML)", "Acute Myelogenous Leukemia (AML)", "Myelodysplastic Syndrome (MDS)", "Juvenile Myelomonocytic Leukemia (JMML)", "Acute Lymphoblastic Leukemia (ALL)", "Lymphoma (Hodgkin's and Non-Hodgkin's)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "22 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00867529",
          "briefTitle": "Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2015-03-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["B-cell Adult Acute Lymphoblastic Leukemia", "B-cell Childhood Acute Lymphoblastic Leukemia", "B-cell Chronic Lymphocytic Leukemia", "Childhood Burkitt Lymphoma", "Childhood Diffuse Large Cell Lymphoma", "Childhood Immunoblastic Large Cell Lymphoma", "Cutaneous B-cell Non-Hodgkin Lymphoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Intraocular Lymphoma", "Nodal Marginal Zone B-cell Lymphoma", "Post-transplant Lymphoproliferative Disorder", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Grade III Lymphomatoid Granulomatosis", "Recurrent Childhood Large Cell Lymphoma", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Small Noncleaved Cell Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Small Lymphocytic Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Hairy Cell Leukemia", "Small Intestine Lymphoma", "Splenic Marginal Zone Lymphoma", "Testicular Lymphoma", "Waldenstrm Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT01534143",
          "briefTitle": "High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02"
          },
          "completionDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Refractory Multiple Myeloma", "Stage I Multiple Myeloma", "Stage II Multiple Myeloma", "Stage III Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02259348",
          "briefTitle": "Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia (ALL)", "Acute Myeloid Leukemia (AML)", "Myeloid Sarcoma", "Chronic Myelogenous Leukemia (CML)", "Juvenile Myelomonocytic Leukemia (JMML)", "Myelodysplastic Syndrome (MDS)", "Non-Hodgkin Lymphoma (NHL)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06532084",
          "briefTitle": "Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia, in Relapse", "Myelodysplastic Syndromes", "Chronic Myeloid Leukemia", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 88,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06041893",
          "briefTitle": "Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Haploidentical Hematopoietic Stem Cell Transplantation"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02918292",
          "briefTitle": "Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Aplastic Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06872333",
          "briefTitle": "Allo HSCT for High Risk Hemoglobinopathies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft Failure", "Sickle Cell Disease", "Hemoglobinopathies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01247688",
          "briefTitle": "Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoid Hematological Malignancies", "Umbilical Cord Blood Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02333058",
          "briefTitle": "Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukaemias (ALL)", "Acute Myeloid Leukaemias (AML)", "Myelodysplastic Syndromes (MDS)", "Juvenile Myelomonocytic Leukaemias (JMML)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "28 Days",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02162511",
          "briefTitle": "CD34+ Cell Enriched and T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Mismatched Related Donors or Borderline Organ Function"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2023-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Diseases", "Non-malignant Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04503616",
          "briefTitle": "Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-versus-host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06997471",
          "briefTitle": "Phase I Trial on the Safety of Delayed Infusion of a Nave T Cell-Depleted Hematopoietic Graft With Memory T Cells in Solid Organ Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Solid Organ Transplant Complications", "Solid Organ Transplant Recipients", "Solid Organ Transplant Rejection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01410344",
          "briefTitle": "Allogeneic Transplant in HIV Patients (BMT CTN 0903)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "HIV"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03427866",
          "briefTitle": "Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelofibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05011422",
          "briefTitle": "Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pediatric Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03655145",
          "briefTitle": "HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Myeloproliferative Syndromes", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 344,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05675319",
          "briefTitle": "Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00874315",
          "briefTitle": "Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2012-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neuroblastoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00054327",
          "briefTitle": "Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-11"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05477589",
          "briefTitle": "Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML) in Remission", "Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02766465",
          "briefTitle": "Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 138,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04640987",
          "briefTitle": "Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04935684",
          "briefTitle": "Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia in Remission", "Myelodysplastic Syndromes", "Myeloproliferative Syndrome", "Hodgkin Lymphoma", "Lymphoma, Non-Hodgkin", "Myeloma", "Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07257419",
          "briefTitle": "CD45RA-depleted CD19-CAR T Cell Consolidation After TCR??+ T Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2034-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed Pediatric ALL", "Hematopoietic Cell Transplantation", "Hematologic Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01861106",
          "briefTitle": "Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["GATA2", "Immunodeficiency", "MDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 144,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03408210",
          "briefTitle": "Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndromes", "Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 191,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "8 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05322850",
          "briefTitle": "Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoid Leukemia", "Mixed Phenotype Acute Leukemia", "Acute Undifferentiated Leukemia", "Chronic Myeloid Leukemia in Myeloid Blast Crisis", "Chronic Myeloid Leukemia in Lymphoid Blast Crisis (Diagnosis)", "Chronic Myeloid Leukemia - Accelerated Phase"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06498973",
          "briefTitle": "Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02282904",
          "briefTitle": "Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10-23"
          },
          "completionDateStruct": {
            "date": "2019-12-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Granulomatous Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07047456",
          "briefTitle": "Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00859586",
          "briefTitle": "Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2014-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Leukemia, Lymphoblastic, Acute", "Leukemia, Myelocytic, Chronic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "8 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04528355",
          "briefTitle": "Data Collection Study of Patients with Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT with RIC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Immunodeficiency (PID)", "Congenital Bone Marrow Failure Syndromes", "Inherited Metabolic Disorders (IMD)", "Hereditary Anemias", "Inflammatory Conditions"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Months",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01491958",
          "briefTitle": "Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-06-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Lymphocytic Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02646839",
          "briefTitle": "KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00589563",
          "briefTitle": "Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-05"
          },
          "completionDateStruct": {
            "date": "2012-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloproliferative Disorders", "Graft Versus Host Disease", "Infection", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Precancerous Condition", "Secondary Myelofibrosis", "Small Intestine Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01300611",
          "briefTitle": "TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01"
          },
          "completionDateStruct": {
            "date": "2020-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Double Cord Blood Transplant", "Acute Myelogenous Leukemia", "Myelodysplastic Syndrome", "Myelofibrosis", "Acute Lymphoblastic Leukemia", "Chronic Myelocytic Leukemia", "Non Hodgkins Lymphoma", "Hodgkins Lymphoma", "Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00548717",
          "briefTitle": "Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-vs-Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05726682",
          "briefTitle": "A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Allogenic Stem Cell Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06225050",
          "briefTitle": "M-2018-334 in Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-02-28",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00723099",
          "briefTitle": "Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Aggressive Non-Hodgkin Lymphoma", "Chronic Myelogenous Leukemia", "Chronic Phase Chronic Myelogenous Leukemia", "Indolent Non-Hodgkin Lymphoma", "Lymphoma", "Mixed Phenotype Acute Leukemia", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm", "Recurrent Chronic Lymphocytic Leukemia", "Recurrent Follicular Lymphoma", "Recurrent Lymphoplasmacytic Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Plasma Cell Myeloma", "Recurrent Small Lymphocytic Lymphoma", "Recurrent T-Cell Non-Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Refractory Chronic Myelogenous Leukemia", "Refractory Follicular Lymphoma", "Refractory Hodgkin Lymphoma", "Refractory Lymphoplasmacytic Lymphoma", "Refractory Mantle Cell Lymphoma", "Refractory Small Lymphocytic Lymphoma", "T-Cell Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02789228",
          "briefTitle": "Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Solid Tumors"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04328714",
          "briefTitle": "Interferon -Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04990323",
          "briefTitle": "US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["High Risk Myeloid Malignancies", "Cord Blood Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00393380",
          "briefTitle": "Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09"
          },
          "completionDateStruct": {
            "date": "2012-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Chronic", "Anemia, Aplastic", "Myelofibrosis", "Lymphoma", "Hodgkin Disease", "Leukemia, Lymphocytic, Chronic", "Leukemia, Myelocytic, Acute", "Leukemia, Lymphocytic, Acute"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01634217",
          "briefTitle": "Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Lymphocytic Leukemia", "Chronic Myelogenous Leukemia", "Non-Hodgkin Lymphoma", "Hodgkin Lymphoma", "Chronic Lymphocytic Leukemia", "Multiple Myeloma", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01966510",
          "briefTitle": "Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03"
          },
          "completionDateStruct": {
            "date": "2017-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Patients With Advanced Lymphoid Malignancies in the Absence of an HLA Identical or Mismatch Donor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00616954",
          "briefTitle": "A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Allogeneic Haplo-Stem Cell Transplatation (SCT)", "Graft Versus Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05926063",
          "briefTitle": "Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neutropenia, Febrile"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 410,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00594308",
          "briefTitle": "In-Vivo Activated T-Cell Depletion to Prevent GVHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Lymphocytic Leukemia", "Chronic Myelogenous Leukemia", "Chronic Lymphocytic Leukemia", "Myelodysplasia", "Lymphoma, Non-Hodgkin's", "Mantle-Cell Lymphoma", "Hodgkin's Disease", "Multiple Myeloma", "Myelofibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06731504",
          "briefTitle": "HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05236764",
          "briefTitle": "Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myeloid Leukemia", "Hemophagocytic Lymphohistiocytoses", "Primary Immunodeficiency Diseases", "Hemoglobinopathies", "Severe Aplastic Anemia", "Cytopenia", "Bone Marrow Failure Syndrome", "Severe Chronic Active Epstein-Barr Virus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00612716",
          "briefTitle": "Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1999-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06954987",
          "briefTitle": "Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-03-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-05-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 244,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04207320",
          "briefTitle": "Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01323920",
          "briefTitle": "Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06559176",
          "briefTitle": "A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Granulomatous Disease", "Granulomatous Disease, Chronic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00908180",
          "briefTitle": "Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-07"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 47,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05907746",
          "briefTitle": "Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["GATA2", "Immunodeficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06082947",
          "briefTitle": "T Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic Stem Cell Transplantation", "Hematologic Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06646497",
          "briefTitle": "Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Aplastic Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05415410",
          "briefTitle": "Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "GVHD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00290641",
          "briefTitle": "Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-04"
          },
          "completionDateStruct": {
            "date": "2006-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04688021",
          "briefTitle": "A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Graft-versus-host-disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02204904",
          "briefTitle": "Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["X-Linked Adrenoleukodystrophy (X-ALD)", "Cerebral Adrenoleukodystrophy (CALD)", "Adrenoleukodystrophy (ALD)"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07015684",
          "briefTitle": "131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-03-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sickling Disorder Due to Hemoglobin S"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06845592",
          "briefTitle": "Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High-risk Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukaemia (AML)", "Acute Lymphoblastic Leukemia ALL", "High Risk Leukaemia", "Leukaemia Relapse"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 51,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05126849",
          "briefTitle": "Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Refractory Idiopathic Aplastic Anemia", "Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00816413",
          "briefTitle": "Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2010-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "Nonmalignant Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00563589",
          "briefTitle": "Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-08"
          },
          "completionDateStruct": {
            "date": "2008-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft vs Host Disease", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02782546",
          "briefTitle": "Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05436418",
          "briefTitle": "The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Peripheral Blood Stem Cell Transplantation", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05027945",
          "briefTitle": "A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Immunodeficiency", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06859424",
          "briefTitle": "A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML (Acute Myelogenous Leukemia)", "Acute Lymphoid Leukemia (ALL)", "Acute Leukemia (Category)", "MDS (Myelodysplastic Syndrome)", "CML (Chronic Myelogenous Leukemia)", "CLL (Chronic Lymphocytic Leukemia)", "Prolymphocyctic Leukemia", "Chronic Myelomonocytic Leukemia (CMML)", "Myeloproliferative Neoplasm (MPN)", "Lymphoma", "Myelofibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "66 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07205523",
          "briefTitle": "High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2100-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic Stem Cell Transplantation (HSCT)", "Acute Myeloid Leukemia (AML)", "Leukemias, Acute Myeloid", "Myeloid Leukemias, Acute", "Hemophilia", "Myelodysplastic Syndrome", "MDS", "Lymphoma", "Leukemia", "Aplastic Anemia", "Bleeding Disorders", "Bone Marrow Transplantation", "Multiple Myeloma", "Myeloma, Multiple", "Immune Reconstitution"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05126186",
          "briefTitle": "Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Diseases", "Graft Failure", "Allogeneic Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05507827",
          "briefTitle": "Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00427661",
          "briefTitle": "A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-06"
          },
          "completionDateStruct": {
            "date": "2014-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sickle Cell Disease", "Thalassemia", "Hemoglobinopathies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01119066",
          "briefTitle": "HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myelogenous Leukemia", "Myelodysplastic Syndrome", "Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 422,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00775931",
          "briefTitle": "Allogeneic Transplantation For Severe Osteopetrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2013-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Osteopetrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Day",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00301912",
          "briefTitle": "Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-01"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Anemia", "Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01349101",
          "briefTitle": "A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02122081",
          "briefTitle": "Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "de Novo Myelodysplastic Syndromes", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Secondary Myelodysplastic Syndromes", "Untreated Adult Acute Lymphoblastic Leukemia", "Untreated Adult Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02029638",
          "briefTitle": "BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00579111",
          "briefTitle": "Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic and Myeloproliferative Disorders", "Acute Myelogenous Leukemia", "Acute Lymphoblastic Leukemia", "Chronic Myelogenous Leukemia", "Multiple Myeloma", "Plasma Cell Dyscrasia", "Lymphoproliferative Disorders", "Hematologic Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02528877",
          "briefTitle": "Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia in Remission", "Primary Myelofibrosis", "Primary Myelofibrosis, Prefibrotic Stage", "Secondary Acute Myeloid Leukemia", "Secondary Myelofibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01428973",
          "briefTitle": "Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft-Versus-Host Disease", "Hematological Malignancies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01319851",
          "briefTitle": "Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Thalassemia", "Sickle Cell Disease", "Glanzmann Thrombasthenia", "Wiskott-Aldrich Syndrome", "Chronic-granulomatous Disease", "Severe Congenital Neutropenia", "Leukocyte Adhesion Deficiency", "Schwachman-Diamond Syndrome", "Diamond-Blackfan Anemia", "Fanconi Anemia", "Dyskeratosis-congenita", "Chediak-Higashi Syndrome", "Severe Aplastic Anemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06752694",
          "briefTitle": "Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Aplastic Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00916045",
          "briefTitle": "Pilot Study of Unrelated Cord Blood Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2012-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Myelodysplastic Syndromes", "Leukemia, Lymphoblastic, Acute", "Lymphoma, Non-Hodgkin", "Hodgkin Disease", "Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02323867",
          "briefTitle": "Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10"
          },
          "completionDateStruct": {
            "date": "2027-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Lymphoma", "Myelodysplasia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "23 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01597778",
          "briefTitle": "Double Cord Versus Haploidentical (BMT CTN 1101)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphocytic Leukemia", "Acute Myelogenous Leukemia", "Burkitt's Lymphoma", "Follicular Lymphoma", "Hodgkin Lymphoma", "Mantle Cell Lymphoma", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 368,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05929092",
          "briefTitle": "TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic Stem Cell Transplantation", "Malignant Hematological Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05384756",
          "briefTitle": "TMLI and Alemtuzumab for Treatment of Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03139604",
          "briefTitle": "GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-versus-host Disease (GVHD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 439,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06946602",
          "briefTitle": "Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML", "Elderly"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 307,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02728700",
          "briefTitle": "Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02"
          },
          "completionDateStruct": {
            "date": "2018-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Hodgkin Lymphoma", "Adult Myelodysplastic Syndrome", "Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Childhood Hodgkin Lymphoma", "Childhood Myelodysplastic Syndrome", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Myelofibrosis", "Primary Myelofibrosis", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Non-Hodgkin Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Non-Hodgkin Lymphoma", "Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Refractory Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00691015",
          "briefTitle": "Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2014-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01181271",
          "briefTitle": "Tandem Auto-Allo Transplant for Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse, Large B-Cell, Lymphoma", "Lymphoma, Low-Grade", "T-Cell Lymphoma", "Mantle-Cell Lymphoma", "Hodgkin's Lymphoma", "Chronic Lymphocytic Leukemia", "Lymphoma, Small Lymphocytic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03579875",
          "briefTitle": "Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-01-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Fanconi Anemia", "Severe Aplastic Anemia", "Myelodysplastic Syndromes", "T Cell Receptor Alpha/Beta Depletion", "Telomere Biology Disorder", "Bone Marrow Failure", "Dyskeratosis Congenita", "Telomere Biology Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04326764",
          "briefTitle": "Panobinostat Maintenance After HSCT fo High-risk AML and MDS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukaemia (AML)", "Myelodysplastic Syndromes (MDS)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01056614",
          "briefTitle": "Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-09"
          },
          "completionDateStruct": {
            "date": "2016-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Blastic Phase Chronic Myelogenous Leukemia", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Chronic Phase Chronic Myelogenous Leukemia", "de Novo Myelodysplastic Syndromes", "Hematopoietic/Lymphoid Cancer", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Previously Treated Myelodysplastic Syndromes", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Relapsing Chronic Myelogenous Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "60 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT06235398",
          "briefTitle": "Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndromes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07284641",
          "briefTitle": "Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2031-12-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Common Variable Immunodeficiency (CVID)", "Primary Immune Regulatory Disorder", "Immune Dysregulation", "DiGeorge Syndrome", "STAT 1 Gain of Function", "STAT 3 Gain of Function", "Hypomorphic RAG1 Deficiency", "CD40 Ligand Deficiency", "Mendelian Susceptibility to Mycobacterial Disease", "GATA2 Associated Immunodeficiency", "CD40 Deficiency", "Hypomorphic RAG2 Deficiency", "Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome", "Omenn Syndrome", "Chronic Granulomatous Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00453388",
          "briefTitle": "Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia in Remission", "de Novo Myelodysplastic Syndrome", "Fanconi Anemia", "Previously Treated Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06427330",
          "briefTitle": "Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Lymphoid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04187105",
          "briefTitle": "BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "MDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00119392",
          "briefTitle": "Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-06"
          },
          "completionDateStruct": {
            "date": "2016-04-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["B-cell Chronic Lymphocytic Leukemia", "Nodal Marginal Zone B-cell Lymphoma", "Recurrent Adult Burkitt Lymphoma", "Recurrent Adult Diffuse Large Cell Lymphoma", "Recurrent Adult Diffuse Mixed Cell Lymphoma", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Immunoblastic Large Cell Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Grade 3 Follicular Lymphoma", "Recurrent Mantle Cell Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Small Lymphocytic Lymphoma", "Splenic Marginal Zone Lymphoma", "Waldenstrm Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00719888",
          "briefTitle": "Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Biphenotypic Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Burkitt Lymphoma", "Chronic Lymphocytic Leukemia", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Follicular Lymphoma", "Lymphoblastic Lymphoma", "Lymphoplasmacytic Lymphoma", "Mantle Cell Lymphoma", "Marginal Zone Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Non-Hodgkin Lymphoma", "Plasma Cell Myeloma", "Prolymphocytic Leukemia", "Refractory Anemia", "Small Lymphocytic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 135,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01384513",
          "briefTitle": "A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Aplastic Anemia", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Myelodysplastic Syndromes", "Chronic Eosinophilic Leukemia", "Chronic Myelomonocytic Leukemia", "Chronic Neutrophilic Leukemia", "Essential Thrombocythemia", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Juvenile Myelomonocytic Leukemia", "Mastocytosis", "Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable", "Nodal Marginal Zone B-cell Lymphoma", "Polycythemia Vera", "Previously Treated Myelodysplastic Syndromes", "Primary Myelofibrosis", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Diffuse Small Cleaved Cell Lymphoma", "Recurrent Adult Grade III Lymphomatoid Granulomatosis", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma", "Recurrent Grade 1 Follicular Lymphoma", "Recurrent Grade 2 Follicular Lymphoma", "Recurrent Marginal Zone Lymphoma", "Recurrent Mycosis Fungoides/Sezary Syndrome", "Recurrent Small Lymphocytic Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Refractory Anemia", "Refractory Anemia With Ringed Sideroblasts", "Refractory Hairy Cell Leukemia", "Refractory Multiple Myeloma", "Secondary Myelodysplastic Syndromes", "Splenic Marginal Zone Lymphoma", "T-cell Large Granular Lymphocyte Leukemia", "Waldenstrm Macroglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01175785",
          "briefTitle": "Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia", "Adult Acute Myeloid Leukemia in Remission", "Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities", "Adult Acute Myeloid Leukemia With Del(5q)", "Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)", "Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)", "Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Chronic Phase Chronic Myelogenous Leukemia", "de Novo Myelodysplastic Syndromes", "Previously Treated Myelodysplastic Syndromes", "Refractory Anemia", "Refractory Anemia With Excess Blasts", "Refractory Anemia With Excess Blasts in Transformation", "Relapsing Chronic Myelogenous Leukemia", "Secondary Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03862833",
          "briefTitle": "Zoledronic Acid in Combination With Interleukin-2 to Expand V9V2 T Cells After T-replete Haplo-identical Allotransplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematopoietic Stem Cell Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04370301",
          "briefTitle": "Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Myelofibrosis", "Secondary Myelofibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04013685",
          "briefTitle": "Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoid Leukemia", "Myelodysplastic Syndromes", "Acute Leukemia", "Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)", "Chronic Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 255,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02626715",
          "briefTitle": "Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Myelodysplastic Syndrome (MDS)", "Hematopoietic Stem Cell Transplant (HSCT)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Months",
          "maximumAge": "26 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06802315",
          "briefTitle": "Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia, Relapsed, Adult", "Acute Myeloid Leukemia Refractory", "Chronic Myeloid Leukemia - Accelerated Phase", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06548958",
          "briefTitle": "A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Hematological Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02683525",
          "briefTitle": "Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft vs Host Disease", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05005299",
          "briefTitle": "Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Leukemia, Lymphoblastic, Acute, L1", "Leukemia, Lymphoblastic, Acute, L2", "Myelodysplastic Syndromes", "Non-hodgkin Lymphoma", "Plasma Cell Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01244906",
          "briefTitle": "Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00167219",
          "briefTitle": "Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1999-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Myelomonocytic Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02793544",
          "briefTitle": "HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndrome (MDS)", "Chronic Lymphocytic Leukemia (CLL)", "Chemotherapy-sensitive Lymphoma", "Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma", "Acute Myelogenous Leukemia (AML)", "Acute Biphenotypic Leukemia (ABL)", "Acute Undifferentiated Leukemia (AUL)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01045382",
          "briefTitle": "MSC and HSC Coinfusion in Mismatched Minitransplants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Leukemia, Lymphoblastic, Acute", "Leukemia, Myelocytic, Chronic", "Myeloproliferative Disorders", "Myelodysplastic Syndromes", "Multiple Myeloma", "Leukemia, Lymphocytic, Chronic", "Hodgkin's Disease", "Lymphoma, Non-Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02178683",
          "briefTitle": "Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2018-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00504803",
          "briefTitle": "Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2010-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06000982",
          "briefTitle": "Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "GVHD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 138,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03959241",
          "briefTitle": "TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Chronic Myelogenous Leukemia (CML)", "Myelodysplasia", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 431,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04629430",
          "briefTitle": "Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Myeloma", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Non Hodgkin Lymphoma", "Acute Lymphocytic Leukemia", "Hodgkin Lymphoma", "Hodgkin Disease", "Myelofibrosis", "Myelodysplastic Syndromes", "Myeloproliferative Neoplasm", "Sickle Cell Disease", "Mantle Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07020533",
          "briefTitle": "A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-05-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Hematopoietic and Lymphatic System Neoplasm", "Hodgkin Lymphoma", "Lymphoblastic Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05426252",
          "briefTitle": "Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Thalassemia in Children"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03913026",
          "briefTitle": "UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["High Risk Hematologic Malignancy", "Cord Blood Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02861417",
          "briefTitle": "Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic and Lymphoid Cell Neoplasm", "High Risk Acute Myeloid Leukemia", "High Risk Myelodysplastic Syndrome", "Lymphoproliferative Disorder", "Myelodysplastic Syndrome", "Myelodysplastic/Myeloproliferative Neoplasm", "Recurrent Acute Lymphoblastic Leukemia", "Recurrent Acute Myeloid Leukemia", "Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Recurrent High Risk Myelodysplastic Syndrome", "Recurrent Hodgkin Lymphoma", "Recurrent Myelodysplastic Syndrome", "Recurrent Non-Hodgkin Lymphoma", "Recurrent Plasma Cell Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00618540",
          "briefTitle": "Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-01"
          },
          "completionDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Histiocytosis, Langerhans-cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03802695",
          "briefTitle": "A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Mixed Phenotype Acute Leukemia", "Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "78 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02639559",
          "briefTitle": "Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Lymphoblastic Leukemia", "Chronic Myelogenous Leukemia", "Non-Hodgkin's Lymphoma", "Non-Hodgkin Lymphoma", "Hodgkin Disease", "Hodgkins Disease", "Hodgkin's Disease", "Multiple Myeloma", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01328496",
          "briefTitle": "Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematologic Malignancies", "Disorder Related to Transplantation", "Hematopoietic Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04521946",
          "briefTitle": "Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaplastic Ependymoma", "Atypical Teratoid/Rhabdoid Tumor", "Central Nervous System Germ Cell Tumor", "Choroid Plexus Carcinoma", "Intracranial Myeloid Sarcoma", "Malignant Brain Neoplasm", "Malignant Glioma", "Medulloblastoma", "Primitive Neuroectodermal Tumor", "Recurrent Anaplastic Ependymoma", "Recurrent Atypical Teratoid/Rhabdoid Tumor", "Recurrent Malignant Brain Neoplasm", "Recurrent Malignant Glioma", "Recurrent Medulloblastoma", "Recurrent Primitive Neuroectodermal Tumor"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06946654",
          "briefTitle": "Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Elderly", "Geriatric Assessment", "ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 176,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06705062",
          "briefTitle": "Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination with Post-engraftment Anti-thymoglobin As Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Allogeneic Hematopoietic Cell Transplant", "Graft Versus Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 316,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04728490",
          "briefTitle": "Haplo-identical Transplantation in Patients With Myelofibrosis - A Phase 2 Prospective Multicentric Prospective Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myelofibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 28,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03663751",
          "briefTitle": "Low-dose Decitabine for the Treatment of Decreased Donor Chimerism After Allogeneic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Response Rate"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04060277",
          "briefTitle": "Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-04-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Hematopoietic and Lymphoid Cell Neoplasm", "Hodgkin Lymphoma", "Lymphoblastic Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04888741",
          "briefTitle": "Methods of T Cell Depletion Trial (MoTD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndromes", "Non Hodgkin Lymphoma", "Hodgkin Lymphoma", "Multiple Myeloma", "Chronic Myelogenous Leukemia", "Myelofibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01875237",
          "briefTitle": "Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Myeloma", "Myeloproliferative Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00305682",
          "briefTitle": "Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 295,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04395092",
          "briefTitle": "Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia (AML)", "Myelodysplastic Syndromes (MDS)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00651716",
          "briefTitle": "T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2019-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Breast Cancer", "Chronic Myeloproliferative Disorders", "Gestational Trophoblastic Tumor", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Neuroblastoma", "Ovarian Cancer", "Testicular Germ Cell Tumor"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03852407",
          "briefTitle": "Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2038-11-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia in Remission", "Myelodysplastic Syndromes", "Chronic Myeloid Leukemia in Remission", "Myeloproliferative Syndrome", "Myeloproliferative Disorder", "Acute Lymphoid Leukemia in Remission", "Multiple Myeloma", "Chronic Lymphoid Leukemia", "Non Hodgkin Lymphoma", "Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 114,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04523376",
          "briefTitle": "Pilot Study PBSCT with TCRab Depletion for Hemoglobinopathies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Sickle Cell Disease", "Thalassemia Major"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02722668",
          "briefTitle": "UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia/Lymphoma", "Burkitt's Lymphoma", "Natural Killer Cell Malignancies", "Chronic Myelogenous Leukemia", "Myelodysplastic Syndrome", "Large-cell Lymphoma", "Hodgkin Lymphoma", "Multiple Myeloma", "Relapsed Chronic Lymphocytic Leukemia", "Relapsed Small Lymphocytic Lymphoma", "Marginal Zone B-cell Lymphoma", "Follicular Lymphoma", "Lymphoplasmacytic Lymphoma", "Mantle-cell Lymphoma", "Prolymphocytic Leukemia", "Bone Marrow Failure Syndromes", "Myeloproliferative Neoplasms/Myelofibrosis", "Biphenotypic/Undifferentiated/Prolymphocytic Leukemias", "MRD Positive Leukemia", "Leukemia or MDS in Aplasia", "Relapsed T-Cell Lymphoma", "Relapsed Multiple Myeloma", "Plasma Cell Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06294691",
          "briefTitle": "Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Graft-versus-host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 198,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00281879",
          "briefTitle": "Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02"
          },
          "completionDateStruct": {
            "date": "2008-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Unusual Cancers of Childhood"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00309842",
          "briefTitle": "Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphocytic Leukemia", "Chronic Myelogenous Leukemia", "Myelofibrosis", "MDS", "Refractory Anemia", "Chronic Lymphocytic Leukemia", "Prolymphocytic Leukemia", "Non-Hodgkin's Lymphoma", "Leukemia", "Lymphoma", "Multiple Myeloma", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 213,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06879847",
          "briefTitle": "A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03560752",
          "briefTitle": "CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase CML, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Chronic Lymphocytic Leukemia", "Chronic Phase CML, BCR-ABL1 Positive", "Cytomegalovirus Positive", "Donor", "Hematopoietic Cell Transplant Recipient", "Hodgkin Lymphoma", "Myelodysplastic Syndrome", "Myelodysplastic/Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma", "Myelofibrosis", "Hematopoietic and Lymphoid Cell Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05170828",
          "briefTitle": "Cryopreserved MMUD BM With PTCy for Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Myelodysplastic Syndromes", "T-lymphoblastic Lymphoma", "Acute Lymphocytic Leukemia", "Acute Myeloid Leukemia", "Acute Biphenotypic Leukemia", "Acute Undifferentiated Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00003145",
          "briefTitle": "Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1997-08"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase of Disease", "Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Phase of Disease", "Recurrent Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02120157",
          "briefTitle": "Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myeloablative Conditioning", "HLA-mismatched Bone Marrow Transplantation", "Graft Survival", "Transplantation, Bone Marrow"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06480630",
          "briefTitle": "Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Graft Versus Host Disease", "Malignant Hematologic Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00505895",
          "briefTitle": "FM 140 vs FM100 Study in Patients With Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-01"
          },
          "completionDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06158828",
          "briefTitle": "Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCR T Cell Depleted Haploidentical Transplant in AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["AML, Childhood", "Aml", "Acute Myeloid Leukemia, Pediatric", "Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06926894",
          "briefTitle": "R-MVST Cells for Treatment of Viral Infections in Children and Young Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Epstein-Barr Virus", "Cytomegalovirus Infections", "Adenovirus", "BK Virus Infection", "Immune Deficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Months",
          "maximumAge": "26 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07015801",
          "briefTitle": "CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2040-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cytomegalovirus Viremia", "Cytomegalovirus Pneumonia", "T-Lymphocyte Immunodeficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "0 Years",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00920972",
          "briefTitle": "Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-12"
          },
          "completionDateStruct": {
            "date": "2031-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Metabolic Disorders", "Hematologic, Immune, or Bone Marrow Disorders", "Hemoglobinopathies", "Non-malignant Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05674539",
          "briefTitle": "Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia, Adult", "Myelodysplastic Syndrome(MDS)", "Allogeneic Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05419843",
          "briefTitle": "Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Aplastic Anemia", "Severe Aplastic Anemia", "Moderate Aplastic Anemia Requiring Transfusions"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00346359",
          "briefTitle": "Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03"
          },
          "completionDateStruct": {
            "date": "2007-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloproliferative Disorders", "Graft Versus Host Disease", "Leukemia", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00027820",
          "briefTitle": "Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-08"
          },
          "completionDateStruct": {
            "date": "2004-09-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adult Acute Myeloid Leukemia in Remission", "Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Myelodysplastic Syndrome", "Childhood Renal Cell Carcinoma", "Chronic Myelomonocytic Leukemia", "Clear Cell Renal Cell Carcinoma", "de Novo Myelodysplastic Syndrome", "Metastatic Renal Cell Cancer", "Previously Treated Myelodysplastic Syndrome", "Progression of Multiple Myeloma or Plasma Cell Leukemia", "Recurrent Adult Acute Lymphoblastic Leukemia", "Recurrent Adult Acute Myeloid Leukemia", "Recurrent Adult Hodgkin Lymphoma", "Recurrent Adult Lymphoblastic Lymphoma", "Recurrent Adult Non-Hodgkin Lymphoma", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Lymphoblastic Lymphoma", "Recurrent Childhood Non-Hodgkin Lymphoma", "Refractory Anemia", "Refractory Anemia With Ringed Sideroblasts", "Refractory Childhood Hodgkin Lymphoma", "Refractory Chronic Lymphocytic Leukemia", "Renal Medullary Carcinoma", "Type 1 Papillary Renal Cell Carcinoma", "Type 2 Papillary Renal Cell Carcinoma", "Untreated Adult Acute Lymphoblastic Leukemia", "Untreated Adult Acute Myeloid Leukemia", "Untreated Childhood Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 106,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02652468",
          "briefTitle": "TCR-/ and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04414046",
          "briefTitle": "TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Immune Deficiency Disorders", "Metabolic Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02750254",
          "briefTitle": "Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndrome", "Acute Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00984412",
          "briefTitle": "Allo-Allo Tandem Bone Marrow Transplant (BMT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11"
          },
          "completionDateStruct": {
            "date": "2020-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Refractory Acute Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04836390",
          "briefTitle": "Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00392782",
          "briefTitle": "Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07"
          },
          "completionDateStruct": {
            "date": "2011-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01951885",
          "briefTitle": "Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myelogenous Leukemia", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Acute Biphenotypic Leukemia", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma", "Hodgkins Disease", "Chronic Lymphocytic Leukemia", "Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 101,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00946023",
          "briefTitle": "Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "B-cell Lymphoma", "Non Hodgkin Lymphoma", "Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 135,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03980769",
          "briefTitle": "Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03250546",
          "briefTitle": "Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematopoietic Stem Cell Transplant"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 184,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01814488",
          "briefTitle": "A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07"
          },
          "completionDateStruct": {
            "date": "2017-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 101,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00622895",
          "briefTitle": "Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Systemic Scleroderma", "Severe Systemic Sclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00429416",
          "briefTitle": "Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-03"
          },
          "completionDateStruct": {
            "date": "2009-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00796068",
          "briefTitle": "Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Biphenotypic Leukemia", "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Blasts Under 5 Percent of Bone Marrow Nucleated Cells", "Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Myelodysplastic Syndrome (MDS)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06615050",
          "briefTitle": "A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-01-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-versus-host Disease (GVHD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 572,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04806347",
          "briefTitle": "Alpha/Beta T-cell Depleted Blood-forming Stem Cell Transplant From Related or Unrelated Donors for Blood Diseases in Children and Young Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Blood Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Months",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03320642",
          "briefTitle": "GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 84,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00943800",
          "briefTitle": "Combined Haploidentical-Cord Blood Transplantation for Adults and Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Myelodysplastic Syndrome", "Multiple Myeloma", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 87,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02828592",
          "briefTitle": "Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Aplastic Anemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04002115",
          "briefTitle": "Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myeloid Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01643668",
          "briefTitle": "Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00326417",
          "briefTitle": "Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-01"
          },
          "completionDateStruct": {
            "date": "2016-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Anemia, Aplastic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 97,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00481832",
          "briefTitle": "Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-01"
          },
          "completionDateStruct": {
            "date": "2017-03-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05183490",
          "briefTitle": "R-MVST Cells for Treatment of Viral Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Epstein-Barr Virus Infections", "Cytomegalovirus Infections", "Adenovirus", "BK Virus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02678143",
          "briefTitle": "Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01570348",
          "briefTitle": "Crohn's Allogeneic Transplant Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01744223",
          "briefTitle": "Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myelogenous Leukemia", "Lymphoma", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03799224",
          "briefTitle": "Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stem Cell Transplant Complications", "Relapse Leukemia", "Refractory Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01174940",
          "briefTitle": "Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06"
          },
          "completionDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stem Cell Leukemia of Unclear Lineage", "Graft Versus Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07046078",
          "briefTitle": "Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia of Ambiguous Lineage", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00496340",
          "briefTitle": "Phase II Trial of Pentostatin and Targeted Busulfan"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-07"
          },
          "completionDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07216443",
          "briefTitle": "Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Myelodysplastic Syndromes", "Mixed Phenotype Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00763490",
          "briefTitle": "Trial Of Double Umbilical Cord Blood Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12"
          },
          "completionDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematological Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00450450",
          "briefTitle": "Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Childhood Acute Lymphoblastic Leukemia in Remission", "Childhood Acute Myeloid Leukemia in Remission", "Childhood Chronic Myelogenous Leukemia", "Childhood Myelodysplastic Syndromes", "Chronic Phase Chronic Myelogenous Leukemia", "de Novo Myelodysplastic Syndromes", "Juvenile Myelomonocytic Leukemia", "Previously Treated Myelodysplastic Syndromes", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Secondary Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      }
    ]
  }
}
